Aktiesnakken — August 2010
-
tror slet ikke det er der den kommer til at hænge,
-
nå... det var hvis nok BioPorto ævl for en aften, vil hoppe i boxen, sov godt..
-
iøvrigt, aftenens chat, er et glimrende eksempel på hvor vigtigt det er at vi her på PI, får vores egen chat, om "Sundhed"
-
hvilket link ?
-
mht. ASR
-
det var bare en beskrivlese af hvordan et diagnostisk selskab kunne "omgås" FDA
-
-
bl.a. Home brew, og så ASR
-
Yet another route is to sell one or more of
the components of their diagnostic to testing
laboratories as analyte-specific reagents
(ASRs), thus enabling early market penetration
and enhancing early adoption of their
technology. -
home brew, selvom Mayo kun bruger testen in house, så må de gerne distribuere den, når de foretager den godkendelse
-
he he, Ebdrups, alle kneb gælder med de konkurrenter, se bare Abbott, de bruger også ufine tricks
-
tror bare at de hysteriske sendte den for langt ned i sidste uge, og det så er en normal korrektion,.
-
ingne særlig årsag ihvertfald, måske lidt med AU, at de opjusterer kortsigtet kursmål, fra 8 til 10, men er lidt i tvivl
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind